Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the Letter to the Editor Entitled "A Missing Genomic Dimension: The Small but Central Mitochondrial Genome in Diabetic Kidney Disease Genetics".

Kidney international reports·2026
Same author

Diagnostic and Clinical Utility of Assessing Renal Functional Reserve: Unmasking Subclinical Kidney Disease.

Kidney360·2026
Same author

Tandem RNA and Protein Extraction: A Platform for Maximizing the Use of Limited Ex Vivo Tissue Samples.

Bio-protocol·2026
Same author

Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney Disease.

Diabetes·2026
Same author

Exome-Wide Analysis Identifies a Rare <i>EXD3</i> Missense Variant Associated With Diabetic Kidney Disease.

Kidney international reports·2026
Same author

TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis.

Circulation research·2025
Same journal

Glucagon-like peptide-1 improves vascular endothelial dysfunction in hypertensive mice via CREB-driven transcriptional regulation of long non-coding RNA 155383.

British journal of pharmacology·2026
Same journal

The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.

British journal of pharmacology·2026
Same journal

Peripheral targets for neuropathic pain.

British journal of pharmacology·2026
Same journal

Therapeutic potential of liver X receptor agonist GW3965 in preserving myelin integrity following traumatic brain injury.

British journal of pharmacology·2026
Same journal

The role of protein arginine methyltransferases in sickle cell-mediated neurovascular impairments in mice.

British journal of pharmacology·2026
Same journal

β-Cyclodextrin inclusion enhances the pro-resolving effects of the annexin A1 mimetic Ac2-26 in a mouse model of antigen-induced arthritis.

British journal of pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

Lipoxins: resolutionary road.

Paola Maderna1, Catherine Godson

  • 1UCD Diabetes Research Centre, UCD Conway Institute, School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland.

British Journal of Pharmacology
|September 30, 2009
PubMed
Summary
This summary is machine-generated.

Lipoxins (LXs) are key mediators that actively resolve inflammation by limiting immune cell traffic and promoting the clearance of apoptotic cells. These lipid mediators also show potential as anti-fibrotic agents, offering therapeutic benefits.

More Related Videos

Ultrafast Lignin Extraction from Unusual Mediterranean Lignocellulosic Residues
09:22

Ultrafast Lignin Extraction from Unusual Mediterranean Lignocellulosic Residues

Published on: March 9, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

Ultrafast Lignin Extraction from Unusual Mediterranean Lignocellulosic Residues
09:22

Ultrafast Lignin Extraction from Unusual Mediterranean Lignocellulosic Residues

Published on: March 9, 2021

Area of Science:

  • Immunology
  • Biochemistry
  • Pharmacology

Background:

  • Inflammation resolution is an active, mediator-controlled process.
  • Lipid mediators, including lipoxins (LXs), resolvins, and protectins, play crucial roles in regulating inflammation.
  • LXs were the first identified endogenous mediators promoting inflammation resolution.

Purpose of the Study:

  • To review the biosynthesis, metabolism, and bioactions of lipoxins (LXs) and their analogues.
  • To update on recent studies investigating the therapeutic potential of LXs.
  • To highlight LXs' roles in promoting inflammation resolution and as anti-fibrotic agents.

Main Methods:

  • Literature review of biosynthesis, metabolism, and bioactions of LXs.
  • Analysis of recent studies on LX analogues and their therapeutic applications.
  • Examination of LXs' effects on leukocyte trafficking, apoptotic cell clearance, and fibrotic processes.

Main Results:

  • LXs act as 'braking signals,' limiting leukocyte migration to inflammatory sites.
  • LXs stimulate macrophages to phagocytose apoptotic cells, aiding resolution.
  • LXs demonstrate potential anti-fibrotic effects by modulating pro-fibrotic cytokines and gene expression.

Conclusions:

  • LXs are critical endogenous mediators actively involved in resolving inflammation.
  • LXs possess therapeutic potential as promoters of resolution and inhibitors of fibrosis.
  • Further research into LXs and their analogues could lead to novel anti-inflammatory and anti-fibrotic therapies.